Corbus Pharmaceuticals Holdings (CRBP) Return on Capital Employed Growth (1y) (2015 - 2025)
Corbus Pharmaceuticals Holdings (CRBP) Return on Capital Employed Growth (1y) (2015 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 45.00 |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | -48.00 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -785.00 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 1,629.00 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 3,193.00 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -28.00 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 399.00 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | -310.00 |
| 10 | Corbus Pharmaceuticals Holdings | 127.63 Mn | -35.64 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -4,421.00 |
| Jun 30, 2025 | -2,126.00 |
| Mar 31, 2025 | 3,002.00 |
| Dec 31, 2024 | 1.17 Mn |
| Sep 30, 2024 | 50,940.00 |
| Jun 30, 2024 | 10,707.00 |
| Mar 31, 2024 | 3,574.00 |
| Dec 31, 2023 | -1.17 Mn |
| Sep 30, 2023 | -47,641.00 |
| Jun 30, 2023 | -8,099.00 |
| Mar 31, 2023 | -5,226.00 |
| Dec 31, 2022 | -1,143.00 |
| Sep 30, 2022 | 34.00 |
| Jun 30, 2022 | 1,677.00 |
| Mar 31, 2022 | 5,429.00 |
| Dec 31, 2021 | 12,490.00 |
| Sep 30, 2021 | 16,757.00 |
| Jun 30, 2021 | 22,624.00 |
| Mar 31, 2021 | 24,632.00 |
| Dec 31, 2020 | 14,183.00 |